Skip to content

Clinical trials

Observational Hemophilia B trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Phase: Observational Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20091
20101
20142
20151
20171
20182
20193
20201
20214
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting3
Unknown status3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swedish Orphan Biovitrum3
Assistance Publique - Hôpitaux de Paris2
CSL Behring2
Novo Nordisk A/S2
Wyeth is now a wholly owned subsidiary of Pfizer2
ApcinteX Ltd1
Baxalta now part of Shire1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier Universitaire de Saint Etienne1
Groupe Maladies hémorragiques de Bretagne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B22
Hemophilia A13
Blood Coagulation Disorders2
Hematologic Diseases2
Anemia, Sickle Cell1
Blood Coagulation Disorders, Inherited1
Coagulation Protein Disorders1
Cystic Fibrosis1
Fragile X Syndrome1
Genetic Diseases, Inborn1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.